Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.
By Lubna Patrawala, Tammy Calhoun, Robin Schneider‐Broussard, Jianjun Zhou, K. Claypool, D. Tang. Cancer Research, 2005
992 citations recorded by the source corpus.
Subfields: Molecular Biology, Oncology
View Paper: https://www.semanticscholar.org/paper/f4f4c68bc8db8977e9ea34c76d63bc0b894b0f41
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- Angelo Luigi Vescovi
- K. Polyak
- J. Lieberman
- E. Song
- A. Richardson
- Rameen Beroukhim
- Eric C. Holland
- Jason T. Huse
In Oncology
- K. Polyak
- E. Song
- A. Richardson
- Angelo Luigi Vescovi
- Eric C. Holland
- R. DePinho
- R. Weinberg
- D. Hanahan
Citations in the corpus
- Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. (2006, background): “EGFR FISH was performed using centromere 7 and an EGFR probe set ( Vysis ) .”
- Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells (2006, methodology): “In contrast, the highly purified ABCG2þ (which mediates the SP phenotype in some cell types) PCa cell population has very similar tumorigenic potentials to the ABCG2 cells (Patrawala et al., 2005).”
- Molecular definition of breast tumor heterogeneity. (2007, background): “Subsequent studies in breast and prostate cancer confirmed that CD44+ cells are tumorigenic when injected into immunodeficient mice and have progenitor-like properties (Patrawala et al., 2005; Ponti et al., 2005).”
- Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44 (2009, background): “which expressed ABCG2, an ATP-binding cassette half-transporter that is associated with SP cells, had a similar tumorigenicity as ABCG2-negative cells [54].”
- let-7 regulates self renewal and tumorigenicity of breast cancer cells. (2007, methodology): “Both the mammospheres and sorted cells, composed mostly of BT-IC and EPC (Al-Hajj et al., 2003; Ponti et al., 2005), from patients in Table S1A, had reduced let-7 as compared with either adherent cells or tumor cells that were not CD44+CD24 (p < 0.01).”
- Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. (2006, background): “It has been shown that stem-like ‘‘side-populations’’ in established brain tumor cell lines are uniquely able to form xenografts (25, 26).”
- Genetics and biology of prostate cancer (2018, background): “Several prostate cancer cell-intrinsic chemoresistance mechanisms include activation of ABCG2 (Robey et al. 2001; Imai et al. 2004; Patrawala et al. 2005), activation of PI3K signaling (Lee et al. 2004), loss of RAS-GTPase-activating protein DAB2IP (Wu et al. 2013), up-regulation of cancer stem…”
- Cyclopamine‐Mediated Hedgehog Pathway Inhibition Depletes Stem‐Like Cancer Cells in Glioblastoma (2007, background): “lines such as C6, U87-MG, and U373 and that the side population within the C6 and U373 lines appears to be uniquely capable of forming tumor xenografts [31, 49 ].”